Head Computed Tomography for Predicting Neurological Outcome After Cardiac Arrest

NCT03913065 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2024-03-22

No results posted yet for this study

Summary

The European Resuscitation Council (ERC) and the European Society of Intensive Care Medicine (ESICM) joint guidelines for post-resuscitation care recommend a multimodal approach to prognostication of neurological outcome.

However, head computed tomography (CT) which is commonly used for predicting long-term neurological outcome after cardiac arrest has not yet been examined prospectively in a clinical trial.

The primary purpose of the TTM-2 CT-substudy is to prospectively investigate and compare various methods of diagnosing generalized oedema on CT after cardiac arrest and it´s ability to predict long-term neurological outcome.

Conditions

  • Heart Arrest, Out-Of-Hospital
  • Computed Tomography
  • Unconsciousness
  • Neurologic Deficits

Interventions

DIAGNOSTIC_TEST

CT

Head computed tomography on patients still unconscious 48 hours after cardiac arrest.Visual evaluation of generalized oedema ("eye-balling"). Manual and automated measurement of the differentiation of gray and white matter (GWR) using circular regions of interest (ROI).

Sponsors & Collaborators

  • Region Skane

    collaborator OTHER
  • Charite University, Berlin, Germany

    collaborator OTHER
  • Halmstad County Hospital

    collaborator OTHER
  • Sahlgrenska University Hospital

    collaborator OTHER
  • Karlstad Central Hospital

    collaborator OTHER
  • Medical University Innsbruck

    collaborator OTHER
  • University Hospital of Wales

    collaborator OTHER
  • Hopital Lariboisière

    collaborator OTHER
  • Nantes University Hospital

    collaborator OTHER
  • University Hospital, Linkoeping

    collaborator OTHER
  • Lund University

    lead OTHER

Principal Investigators

  • Marion Moseby-Knappe, MD · Lund University and Skane University Hospitals Sweden

  • Tobias Cronberg, MD, PhD · Lund University and Skane University Hospitals Sweden

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-18
Primary Completion
2022-12-31
Completion
2023-03-12

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03913065 on ClinicalTrials.gov